Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
Open accessPublished version of a preprint
The DOI matches its Crossref record; 131 of the 136 references it cites were found in a registry or an index.
Abstract
Macrophages are abundant in the tumor microenvironment (TME), serving as accomplices to cancer cells for their invasion. Studies have explored the biochemical mechanisms that drive pro-tumor macrophage functions; however the role of TME interstitial flow (IF) is often disregarded. Therefore, we developed a three-dimensional microfluidic-based model with tumor cells and macrophages to study how IF affects macrophage migration and its potential contribution to cancer invasion. The presence of either tumor cells or IF individually increased macrophage migration directedness and speed. Interestingly, there was no additive effect on macrophage migration directedness and speed under the simultaneous presence of tumor cells and IF. Further, we present an in silico model that couples chemokine-mediated signaling with mechanosensing networks to explain our in vitro observations. In our model design, we propose IL-8, CCL2, and β-integrin as key pathways that commonly regulate various Rho GTPases. In agreement, in vitro macrophage migration remained elevated when exposed to a saturating concentration of recombinant IL-8 or CCL2 or to the co-addition of a sub-saturating concentration of both cytokines. Moreover, antibody blockade against IL-8 and/or CCL2 inhibited migration that could be restored by IF, indicating cytokine-independent mechanisms of migration induction. Importantly, we demonstrate the utility of an integrated in silico and 3D in vitro approach to aid the design of tumor-associated macrophage-based immunotherapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model demonstrated that macrophages are attracted to regions of high interstitial fluid pressure, mediated by the chemokine CCL2, and can enhance tumor cell migration and invasion through matrix metalloproteinase secretion.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lee et al. (2020)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This integrated approach provided valuable insights into the pivotal role of macrophages in tumor progression and metastasis.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lee et al. (2020)
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“| PDAC | Lee et al. (2020) | Microfluidic chip with 4 connected channels | Panc-1 PDAC cells and macrophages | Interstitial flow and cancer cell signaling increases macrophage motility |”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lee et al. (2020)
The cited source says what the claim attributes to it.
In the citing paper
“In a separate investigation, Lee and colleagues developed an integrated in vitro and in silico model to examine macrophage migration influenced by biochemical and mechanical factors in the tumor microenvironment (Figure 2D) (Lee et al. (2020).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Lee et al. (2020)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Nishita, M., Park, S.-Y., Nishio, T., Kamizaki, K., Wang, Z., Tamada, K., Takumi, T., Hashimoto, R., Otani, H., Pazour, G. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-016-0028-x · Cited by 15,947
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
An Introduction to Systems Biology: Design Principles of Biological Circuits
Alon, U. (2006) · doi:10.1201/9781420011432 · Cited by 2,825
T cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
Focal adhesion kinase: in command and control of cell motility.
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,335
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Research works printed but not linked: 2
- Bisswanger H. 2001 Enzyme Kinetics. Wiley-VCH. 42 898
- Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, Morand EF, Hickey MJ. 927 2011 Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic 928 responses via MAPK and Rho GTPase. J. Immunol. 186, 4915-4924. 929 (doi:10.4049/jimmunol.1003713) 930 · doi:10.4049/jimmunol.1003713)930
Cited by
Unravelling cell migration: defining movement from the cell surface
Merino-Casallo, F., Gómez‐Benito, M. J., Hervás-Raluy, S., & García‐Aznar, J. M. (2022) · Cell Adhesion & Migration · doi:10.1080/19336918.2022.2055520 · Cited by 130
Macrophages Actively Transport Nanoparticles in Tumors After Extravasation
Lin, Z. P., Nguyen, L. N. M., Ouyang, B., MacMillan, P., Ngai, J., Kingston, B. R., Mladjenovic, S. M., & Chan, W. C. W. (2022) · ACS Nano · doi:10.1021/acsnano.1c11578 · Cited by 128
Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer
Xiao, M., He, J., Yin, L., Chen, X., Zu, X., & Shen, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.799428 · Cited by 120
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 109
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
Shelton, S. E., Nguyen, H. T., Barbie, D. A., & Kamm, R. D. (2021) · iScience · doi:10.1016/j.isci.2020.101985 · Cited by 93
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
Maulana, T. I., Kromidas, E., Wallstabe, L., Cipriano, M., Alb, M., Zaupa, C., Hudecek, M., Fogal, B., & Loskill, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.015 · Cited by 91
Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression
Bi, Y., Shirure, V. S., Liu, R., Cunningham, C., Ding, L., Meacham, J. M., Goedegebuure, S. P., George, S. C., & Fields, R. C. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa017 · Cited by 70
Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives
Vasse, G. F., Nizamoglu, M., Heijink, I. H., Schlepütz, M., van Rijn, P., Thomas, M. J., Burgess, J. K., & Melgert, B. N. (2021) · The Journal of Pathology · doi:10.1002/path.5632 · Cited by 74
Gopal, S., Kwon, S., Ku, B., Lee, D. W., Kim, J., & Dordick, J. S. (2021) · Communications Biology · doi:10.1038/s42003-021-02417-2 · Cited by 73
3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment
Franchi-Mendes, T., Eduardo, R., Domenici, G., & Brito, C. (2021) · Cancers · doi:10.3390/cancers13184610 · Cited by 67
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
Vitale, C., Marzagalli, M., Scaglione, S., Dondero, A., Bottino, C., & Castriconi, R. (2022) · Cancers · doi:10.3390/cancers14041013 · Cited by 61
Micro-engineering and nano-engineering approaches to investigate tumour ecosystems
Kim, M., Panagiotakopoulou, M., Chen, C., Ruiz, S. B., Ganesh, K., Tammela, T., & Heller, D. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00593-3 · Cited by 57
Ravi, K., Manoharan, T. J. M., Wang, K.-C., Pockaj, B. A., & Nikkhah, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122428 · Cited by 47
Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics
Hammel, J. H., Zatorski, J. M., Cook, S. R., Pompano, R. R., & Munson, J. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114111 · Cited by 44
Integration of immune cells in organs-on-chips: a tutorial
van Os, L., Engelhardt, B., & Guenat, O. T. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1191104 · Cited by 41
Quantification of cell migration: metrics selection to model application
Hu, Y., Becker, M. L., & Willits, R. K. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1155882 · Cited by 38
Organ-on-a-Chip and Microfluidic Platforms for Oncology in the UK
Nolan, J., Pearce, O. M. T., Screen, H. R. C., Knight, M. M., & Verbruggen, S. W. (2023) · Cancers · doi:10.3390/cancers15030635 · Cited by 39
FRACTIONAL DYNAMICS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH THE EFFECT OF CHEMOIMMUNOTHERAPY TREATMENT
Jan, R., Razak, N. N. A., Alyobi, S., Khan, Z., HOSSEINI, K., Park, C., Salahshour, S., & Donganont, S. (2023) · Fractals · doi:10.1142/s0218348x24400127 · Cited by 34
A 3D pancreatic tumor model to study T cell infiltration
Mollica, H., Teo, Y. J., Tan, A. S. M., Tan, D. Z. M., Decuzzi, P., Pavesi, A., & Adriani, G. (2021) · Biomaterials Science · doi:10.1039/d1bm00210d · Cited by 32
Self-citationKazerouni, A. S., Gadde, M., Gardner, A. L., Hormuth, D. A., Jarrett, A. M., Johnson, K. E., Lima, E. A. B. F., Lorenzo, G., Phillips, C. M., Brock, A., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101807 · Cited by 39
Wang, R., Zhang, C., Li, D., & Yao, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1057913 · Cited by 33
Richardson, I. M., Calo, C. J., & Hind, L. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661537 · Cited by 30
Abdolahinia, E. D., & Han, X. (2023) · Cancers · doi:10.3390/cancers15174266 · Cited by 30
Manoharan, T. J. M., Ravi, K., Suresh, A. P., Acharya, A. P., & Nikkhah, M. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303658 · Cited by 28
Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies
Ngo, T. K. N., Kuo, C., & Tu, T. (2023) · Biomicrofluidics · doi:10.1063/5.0108792 · Cited by 27
Bretti, G., Ninno, A. D., Natalini, R., Peri, D., & Roselli, N. (2021) · Axioms · doi:10.3390/axioms10040243 · Cited by 24
Rodriguez‐Perdigon, M., Haeni, L., Rothen‐Rutishauser, B., & Rüegg, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1159819 · Cited by 19
Gondal, M. N., & Chaudhary, S. U. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.712505 · Cited by 34
Scott, A. L., Jazwinska, D. E., Kulawiec, D. G., & Zervantonakis, I. K. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401719 · Cited by 16
Parameter estimation techniques for a chemotaxis model inspired by Cancer-on-Chip (COC) experiments
Braun, E. C., Bretti, G., & Natalini, R. (2021) · International Journal of Non-Linear Mechanics · doi:10.1016/j.ijnonlinmec.2021.103895 · Cited by 18
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Zhang, F., Jozani, K. A., Chakravarty, A., Lin, D. S. Y., Hollinger, A., Rajasekar, S., & Zhang, B. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202402946 · Cited by 16
Dynamics of macrophage tumor infiltration
Adebowale, K., Guerriero, J. L., & Mitragotri, S. (2023) · Applied Physics Reviews · doi:10.1063/5.0160924 · Cited by 15
A mechanistic protrusive-based model for 3D cell migration
Merino-Casallo, F., Gómez‐Benito, M. J., Martínez-Cantín, R., & García‐Aznar, J. M. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151255 · Cited by 15
Babaniamansour, P., Jacho, D., Teow, A., Rabino, A., García-Mata, R., & Yildirim-Ayan, E. (2023) · Tissue Engineering. Part A · doi:10.1089/ten.tea.2023.0110 · Cited by 13
Cadavid, J. L., Li, N. T., & McGuigan, A. P. (2024) · Biophysics Reviews · doi:10.1063/5.0179125 · Cited by 12
Recapitulating the Cancer‐Immunity Cycle on a Chip
Lee, Y., Min, J., Kim, S., Park, W., Ko, J., & Jeon, N. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401927 · Cited by 11
Biomaterials meet organ-on-chips – a perspective on tumor modeling
Monteiro, C. F., Deus, I. A., Custódio, C. A., & Mano, J. F. (2024) · International Materials Reviews · doi:10.1177/09506608241303436 · Cited by 10
Si, W., Liu, J., Wang, Y., Ma, H., Zhang, Y., Xu, S., Guo, K., Zhang, Y., Hu, Y., & Zhang, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113074 · Cited by 10
Engineering physical microenvironments to study innate immune cell biophysics
Kalashnikov, N., & Moraes, C. (2022) · APL Bioengineering · doi:10.1063/5.0098578 · Cited by 8
An Agent-Based Interpretation of Leukocyte Chemotaxis in Cancer-on-Chip Experiments
Bretti, G., & Gaetano, A. D. (2022) · Mathematics · doi:10.3390/math10081338 · Cited by 8
Using a probabilistic approach to derive a two-phase model of flow-induced cell migration
Ben-Ami, Y., Pitt‐Francis, J., Maini, P. K., & Byrne, H. M. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.02.017 · Cited by 10
A Scenario-Based Study on Hybrid PDE-ODE Model for Cancer-on-Chip Experiment
Bretti, G., Campanile, E., Menci, M., & Natalini, R. (2024) · SEMA SIMAI Springer series · doi:10.1007/978-3-031-60773-8_3 · Cited by 6
Recent advances on cancer-on-chip models: Development of 3D tumors and tumor microenvironment
Moghimi, N., Hosseini, S. A., Poudineh, M., & Kohandel, M. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00238 · Cited by 7
Crossing Barriers: In Vitro Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Marway, M. K., Bhagentsang, D., Venugopal, C., Singh, S. K., Wylie, R. G., & Zhang, B. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00783 · Cited by 6
Microphysiological systems for metastasis research: a stepwise approach
Sharko, V., Ochoa, I., & Solanas, E. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01110-4 · Cited by 5
Yu, D., Xu, C., Jiang, J., Shen, W., & Zhu, H. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400183 · Cited by 7
Chen, X., 谭东现, Liu, S., Luo, R., Liu, Y., Zhang, M., Li, S., & Xu, J. (2026) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2025.0541 · Cited by 5
Pompa, M., Torre, D. L., Bretti, G., & Gaetano, A. D. (2023) · Axioms · doi:10.3390/axioms12100930 · Cited by 4
3D Coculture between Cancer Cells and Macrophages: From Conception to Experimentation
Quoniou, R., Moreau, E., Cachin, F., Miot-Noirault, E., Chautard, E., & Peyrode, C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01437 · Cited by 5
Investigation of tumour environments through advancements in microtechnology and nanotechnology
Liu, Z., Fan, Y. L., Cui, M., Wang, X., & Zhao, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117230 · Cited by 4
Campanile, E., Colombi, A., & Bretti, G. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109330 · Cited by 2
Weathered, C., Pennington, K. M., Escalante, P., & Pienaar, E. (2022) · Tuberculosis · doi:10.1016/j.tube.2022.102300 · Cited by 2
Targeting Tumor‐Immune Microenvironment with Organoid and Organ‐on‐a‐Chip: An Updated Review
Madani, S., Holman, J. B., Rajput, M. U., Ali, S. W., Shi, Z., Qiu, B., Zhang, A., Li, C., & Ding, W. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202501704 · Cited by 1
Macrophage-matrix interactions: orchestrating the fibrotic response?
Vasse, G. F. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.170746933
Merging On-chip and In-silico Modelling for Improved Understanding of Complex Biological Systems
Bertani, F. R., Bretti, G., Businaro, L., Ninno, A. D., Gerardino, A., & Natalini, R. (2023) · SEMA SIMAI Springer series · doi:10.1007/978-3-031-35715-2_2
Engineering cancer's journey: Emerging tools for metastasis modeling
Edwards, T. A., Wagner, H. L., & Peyton, S. R. (2025) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2025.100631
Engineering 3D perfusion platforms for recapitulating immune responses in vascularized models
Zhang, F. (2024) · MacSphere (McMaster University) · doi:10.71548/18786
Richardson, I. M. (2024) · CU Scholar (University of Colorado Boulder)
Lenz, M., Muliawan, V. S., Nowak, F., Miebach, L., Kersting, S., Schulze, T., Bekeschus, S., Kordaß, T., & Khabipov, A. (2026) · Biology · doi:10.3390/biology15030240
Mechanoresponsive reprogramming of tumor-associated macrophages during cancer progression
Kim, D., Kim, Y., Lee, J., Bajpai, S. K., & Kim, D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1915582
Metadata
- Authors
- Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., Zaman, M. H., & Kamm, A. R. D.
- Affiliations
- Agency for Science, Technology and Research (SG)
- Boston University (US)
- Singapore Immunology Network (SIgN), Agency for Science, Technology, and Research (A*STAR), Singapore
- Massachusetts Institute of Technology (US)
- Corresponding author
- Adriani, Giulia
- Zaman, Muhammad Hamid
- Kamm, and Roger D
- ORCID
- Venue
- Integrative Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04
- Volume
- 12
- Issue
- 4
- Pages
- 90-108
- ISSN
- 1757-9694 (ISSN-L)
- 1757-9708
- PMC
- PMC7167463
- OpenAlex
- W3014795384
- Cited by
- 60
- References
- 136
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 11 · 2023: 15 · 2022: 11 · 2021: 12 · 2020: 3
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Integrative Biology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- National Cancer Institute (NCI-U01 CA177799, NCI-U01 CA214381–01)
- Biomedical Research Council (#H16/99/b0/011, IAF 311006)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, macrophage migration, tumor microenvironment, interstitial fluid flow, chemokine signaling, interleukin-8, MCP-1, beta-integrin, mechanosensing, Rho GTPases, tumor invasion, in silico modeling
- MeSH terms
- Cell Differentiation, Cell Movement, Cell Separation, Humans, Immunotherapy, Macrophages, Models, Theoretical, Signal Transduction, Cytokines, Culture Media, Conditioned, Coculture Techniques, Chemokines, Cell Line, Tumor, Lab-On-A-Chip Devices, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.